NextBio

Help
Description: An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. [PubChem]
Drug Type: Small Molecule; Approved
Pharmacology: Naproxen is a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs). Naproxen has analgesic and antipyretic properties. As with other NSAIDs, its mode of action is not fully understood; however, its ability to inhibit prostaglandin synthesis may be involved in the anti-inflammatory effect.
Mechanism of Action: The mechanism of action of naproxen, like that of other NSAIDs, is believed to be associated with the inhibition of cyclooxygenase activity. Two unique cyclooxygenases have been described in mammals. The constitutive cyclooxygenase, COX-1, synthesizes prostaglandins necessary for normal gastrointestinal and renal function. The inducible cyclooxygenase, COX-2, generates prostaglandins involved in inflammation. Inhibition of COX-1 is thought to be associated with gastrointestinal and renal toxicity while inhibition of COX-2 provides anti-inflammatory activity.
Indication: For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, and acute gout. Also for the relief of mild to moderate pain and the treatment of primary dysmenorrhea.
Half Life: The observed terminal elimination half-life is approximately 15 hours.
View Complete Description




Individual Studies
  • β-adrenergic agonist isoproterenol-induced tachycardia and myocardial necrosis

    Rattus norvegicus Rattus norvegicus | RNA Expression   RNA Expression

    Gene expression was evaluated in the myocardium of male Wistar rats after a single sc administration of 0.5 mg of isoproterenol, a β-adrenergic agonist that causes acute tachycardia with subsequent myocardial necrosis.

    Authors: Mikaelian I, Kanwal C

    Organization: Hoffman-La Roche RIGG 340 Kingsland Stre…

  • RAW 264.7 cells treated with LPS, ISO, PGE2, LPS+ISO and LPS+PGE2

    Mus musculus Mus musculus | RNA Expression   RNA Expression

    Characterization of modulation of TLR ligands by non-TLR ligands using murine RAW 264.7 cells by treating with with LPS, IFN-gamma, 2-methyl-thio-ATP (2MA), PGE(2), and isoproterenol (ISO).

    Authors: Zhu Xiaocui, Chang MiSook, Hsueh Robert et al.

    Organization: California Institute of Technology Biolo…

View All Individual Studies

Thought leaders and organizations working on research involving naproxen.

  • Paola Patrignani
  • Marc C Hochberg
  • Alex Fragoso
  • Gabriele Merciaro
  • Patrizia Di Gregorio
  • Pfizer
  • Pozen
  • Bayer
  • AstraZeneca
  • Primus Pharmaceuticals
  • G. d'Annunzio University
  • University of Matanzas
  • Mahidol University
  • Radboud University Nijmegen Medical Centre
  • New York University School of Medicine

Clinical Trials | 235 trials

Help for Clinical Trials View All

News | 24 stories

Help for News View All

Community

Help for Community
  • No NextBio users were found for “naproxen”.
    Complete your user profile with your interests, if you want others to find you within the NextBio community.

  • No NextBio groups were found for “naproxen”.
    Be the first to start a group and share your interests with others within the NextBio community.